Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Senior Appointments

30 Mar 2010 12:37

RNS Number : 4219J
W.H. Ireland Group PLC
30 March 2010
 



WH Ireland Group Plc

 

Appointment of New Heads of Institutional Sales/Trading and Corporate Finance

 

WH Ireland Group plc (AIM:WHI), the financial services group, is delighted to announce two senior appointments to lead its Institutional Sales/Trading and Corporate Finance operations. Both will be joining in the week commencing 12 April 2010.

 

Russell Hooper joins as Head of Institutional Sales/Trading and will be responsible for coordinating the Group's institutional stockbroking business. Previously, Russell has been Head of European Institutional Client Sales Trading and also Head of Pan European Hedge Fund Sales Trading at Merrill Lynch where he spent 15 years in the Institutional Equities division. He graduated in Materials Engineering from Cardiff University. His interests include cricket, rugby (Welsh) and cycling.

 

Chris Fielding joins as Head of Corporate Finance, bringing with him over 20 years' experience in corporate finance as a small/mid cap specialist. Since 2005, Chris has worked at Arden Partners, having previously spent eleven years at Hoare Govett, where he was a director of Corporate Finance. He qualified as a chartered accountant with Price Waterhouse. Chris will be based in the Group's London office and will lead the continued expansion of the corporate finance business. Chris' interests and hobbies include rugby (English), skiing, classic cars, travel and walking.

 

The WH Ireland team already has significant depth of experience and strong regional coverage through John Wakefield (Bristol), Dan Bate (Manchester), James Joyce (London) and their respective teams, supported by the Group's award-winning research team, based in Leeds, headed by Matthew Davis. In line with the Group's strategy, these appointments will further enhance WH Ireland's institutional sales and corporate finance offering.

 

Commenting on the appointments, Richard Ford (CEO) said:

 

"We are delighted to have secured the services of two top calibre individuals both of whom bring substantial skill and experience to the firm. These appointments come at a time when we are seeing a significant uplift in client demand for our corporate stockbroking services where we are looking to build our already strong position in the market. Russell and Chris will continue to drive our business forward and complement our existing Securities business both in London and through our principal regional offices in Manchester, Leeds, Birmingham and Bristol."

 

John Wakefield commented:

 

"The two appointments continue the work already in place to address the aspirations of our corporate client base to gain wider access to sources of capital and to benefit from best of breed advice in our core small/mid cap market."

 

Matthew Davis (Head of Institutional Research) said of the appointments:

 

"Both Chris and Russell bring significant experience, further enhancing WH Ireland's distribution capability, both corporately and institutionally."

 

30 March 2010

 

Enquiries:

 

WH Ireland Tel: 020 7220 1666

Richard Ford

 

Biddicks (Financial PR to WH Ireland) Tel: 020 7448 1000

Zoe Biddick

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGFFMGDGGZM
Date   Source Headline
18th Dec 20197:05 amRNSIssue of Options
18th Dec 20197:00 amRNSDirectorate Change - Update
21st Nov 201910:58 amRNSResult of General Meeting
8th Nov 20194:00 pmRNSConfirmation of General Meeting
7th Nov 20197:00 amRNSWH Ireland CIB announces three new appointments
6th Nov 20194:20 pmRNSResult of Placing
6th Nov 20197:10 amRNSProposed Placing
6th Nov 20197:05 amRNSInterim Results
6th Nov 20197:00 amRNSBoard Appointments
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
4th Oct 20197:00 amRNSBoard Changes
27th Sep 20197:00 amRNSDirectorate Change - Update
12th Sep 20192:53 pmRNSResult of AGM
20th Aug 20197:00 amRNSDirectorate Change & Updated Notice of AGM
2nd Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSFinal Results & Notice of AGM
23rd Jul 20197:00 amRNSBoard Appointment
28th Jun 201912:13 pmRNSIssue of Options
25th Jun 20199:19 amRNSDirector/PDMR Shareholding
24th Jun 20197:00 amRNSDirectorate Change Update
13th May 20192:26 pmRNSDirectorate Change Update
24th Apr 20197:00 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20197:00 amRNSDirector/PDMR Shareholding
29th Mar 20197:00 amRNSBoard appointment
26th Mar 20194:44 pmRNSHolding(s) in Company
26th Mar 201910:32 amRNSHolding(s) in Company
21st Mar 20191:59 pmRNSResult of General Meeting
13th Mar 201910:59 amRNSHolding(s) in Company
5th Mar 20194:21 pmRNSResult of Placing and Notice of General Meeting
5th Mar 20197:00 amRNSProposed Placing
6th Feb 20197:00 amRNSDirectorate Changes and Trading Update
21st Dec 20187:00 amRNSDirectorate Change Update
12th Dec 20187:00 amRNSAppointment of New Head of Wealth Management
28th Nov 20187:00 amRNSDirectorate Change
28th Nov 20187:00 amRNSInterim Results
17th Oct 20189:42 amRNSConfirmation of Appointment of CEO
12th Oct 20187:00 amRNSHolding(s) in Company
11th Oct 20182:52 pmRNSHolding(s) in Company
11th Oct 20181:29 pmRNSHolding(s) in Company
10th Oct 20185:10 pmRNSHolding(s) in Company
9th Oct 201811:07 amRNSResult of General Meeting
27th Sep 201812:36 pmRNSResult of AGM & Confirmation of Directorate Change
24th Sep 20184:45 pmRNSHolding(s) in Company
24th Sep 20184:43 pmRNSHolding(s) in Company
20th Sep 201810:36 amRNSShareholder Update, Placing and Notice of GM
20th Sep 201810:35 amRNSHolding(s) in Company
20th Sep 201810:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.